Literature DB >> 15459939

Development of the human fetal pons: in utero ultrasonographic study.

R Achiron1, Z Kivilevitch, S Lipitz, R Gamzu, B Almog, Y Zalel.   

Abstract

OBJECTIVES: To examine the ultrasonographic feasibility of imaging the fetal pons and to construct a reference chart for its normal development during gestation.
METHODS: A cross-sectional, prospective study on 293 healthy fetuses of low-risk pregnancies between 19 and 34 weeks was performed. The transfontanel approach, via the abdominal or vaginal routes, was used to evaluate the fetal metencephalon (pons and cerebellum). The anteroposterior diameter of the fetal pons was measured in a mid-sagittal plane. The longitudinal diameter of the cerebellar vermis was measured at the same plane and the vermis-pons ratio (VPR) was established.
RESULTS: One hundred and forty-four fetuses were in vertex position. In 140 (97.2%) satisfactory visualization and measurements of the pons and cerebellar vermis were obtained. One hundred and forty-nine fetuses were breech presentations and measurements were successfully performed in 147 (98.6%). The pons anteroposterior and vermis longitudinal diameters showed a linear correlation with gestational age (GA) (r = 0.95 for both measurements; P < 0.001). The mean VPR was 1.5 (+/-0.1 SD) and did not change in the gestational interval that was considered.
CONCLUSION: By using the transfontanel approach, evaluation of the fetal pons is feasible via the mid-sagittal plane. The nomograms developed and the ratio to fetal vermis provides reference data that may be helpful when evaluating anomalies of the brainstem.

Entities:  

Mesh:

Year:  2004        PMID: 15459939     DOI: 10.1002/uog.1731

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  8 in total

1.  Normal fetal posterior fossa in MR imaging: new biometric data and possible clinical significance.

Authors:  R Ber; O Bar-Yosef; C Hoffmann; D Shashar; R Achiron; E Katorza
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-05       Impact factor: 3.825

2.  Development of the Fetal Vermis: New Biometry Reference Data and Comparison of 3 Diagnostic Modalities-3D Ultrasound, 2D Ultrasound, and MR Imaging.

Authors:  E Katorza; E Bertucci; S Perlman; S Taschini; R Ber; Y Gilboa; V Mazza; R Achiron
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-31       Impact factor: 3.825

3.  Synchronous Aberrant Cerebellar and Opercular Development in Fetuses and Neonates with Congenital Heart Disease: Correlation with Early Communicative Neurodevelopmental Outcomes, Initial Experience.

Authors:  A Wong; T Chavez; S O'Neil; J Votava-Smith; D Miller; S delCastillo; A Panigrahy; L Paquette
Journal:  AJP Rep       Date:  2017-01

4.  Quantitative Evaluation of the Fetal Cerebellar Vermis Using the Median View on Two-Dimensional Ultrasound.

Authors:  Cenk Gezer; Atalay Ekin; Naciye Sinem Gezer; Ulas Solmaz; Mehmet Ozeren
Journal:  Iran J Radiol       Date:  2016-03-26       Impact factor: 0.212

5.  Structural linear measurements in the newborn brain: accuracy of cranial ultrasound compared to MRI.

Authors:  Lara M Leijser; Latha Srinivasan; Mary A Rutherford; Serena J Counsell; Joanna M Allsop; Frances M Cowan
Journal:  Pediatr Radiol       Date:  2007-05-08

6.  Repetitive breech presentations at term.

Authors:  Pavol Zubor; Imrich Zigo; Jana Sivakova; Petra Moricova; Ivana Kapustova; Stefan Krivus; Jan Danko
Journal:  Case Rep Obstet Gynecol       Date:  2013-07-30

7.  Reference Charts for Fetal Cerebellar Vermis Height: A Prospective Cross-Sectional Study of 10605 Fetuses.

Authors:  Pietro Cignini; Maurizio Giorlandino; Pierpaolo Brutti; Lucia Mangiafico; Alessia Aloisi; Claudio Giorlandino
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

8.  Biometry reference range of the corpus callosum in neonates: An observational study.

Authors:  Yanyan Gao; Kai Yan; Lin Yang; Guoqiang Cheng; Wenhao Zhou
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.